Analysis of Inhaled Corticosteroid Selection in Patients with Bronchial Asthma Using a Questionnaire Survey—Effects of Age, Gender, and Disease Severity—

Background: Inhaled corticosteroid (ICS) has played an important role in the management of asthma. Although several kinds of ICSs are currently available, there is no established strategy for ICS selection. Methods: Using the data from the 2004 questionnaire surveys by the Niigata Asthma Treatment S...

Full description

Bibliographic Details
Main Authors: Kyuma Ota, Takashi Hasegawa, Toshiyuki Koya, Takuro Sakagami, Takashi Sekikawa, Shinichi Toyabe, Kohei Akazawa, Masaaki Arakawa, Fumitake Gejyo, Eiichi Suzuki
Format: Article
Language:English
Published: Elsevier 2009-01-01
Series:Allergology International
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1323893015307188
id doaj-0350329fb89443ab8a9af7a7e6ded301
record_format Article
spelling doaj-0350329fb89443ab8a9af7a7e6ded3012020-11-24T21:10:50ZengElsevierAllergology International1323-89302009-01-0158336537110.2332/allergolint.08-OA-0077Analysis of Inhaled Corticosteroid Selection in Patients with Bronchial Asthma Using a Questionnaire Survey—Effects of Age, Gender, and Disease Severity—Kyuma Ota0Takashi Hasegawa1Toshiyuki Koya2Takuro Sakagami3Takashi Sekikawa4Shinichi Toyabe5Kohei Akazawa6Masaaki Arakawa7Fumitake Gejyo8Eiichi Suzuki9Division of Respiratory Medicine, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.Department of General Medicine, Niigata University Medical and Dental Hospital, Niigata, Japan.Division of Respiratory Medicine, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.Division of Respiratory Medicine, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.Division of Respiratory Medicine, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.Department of Patient Safety, Niigata University Medical and Dental Hospital, Niigata, Japan.Division of Medical Information Science, Niigata University Medical and Dental Hospital, Niigata, Japan.Division of Respiratory Medicine, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.Division of Respiratory Medicine, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.Department of General Medicine, Niigata University Medical and Dental Hospital, Niigata, Japan.Background: Inhaled corticosteroid (ICS) has played an important role in the management of asthma. Although several kinds of ICSs are currently available, there is no established strategy for ICS selection. Methods: Using the data from the 2004 questionnaire surveys by the Niigata Asthma Treatment Study Group, we analyzed relationships between each patient and the ICS employed on the basis of patient background, asthma control and treatment, and indicated characteristics of ICS selection by the physician. Results: Of 2852 cases, 2279 (79.9%) were ICS users, and 1513 (66.4% of ICS users) were classified as being in the fluticasone propionate (FP) group, 438 (19.2%) in the budesonide (BUD) group, and 240 (10.5%) in the hydrofluoroalkane-beclometasone (HFA-BDP) group, indicating that FP was a standard ICS in this study. The mean age was significantly lower in the BUD group (52.3+/−18.2 years) and was significantly higher in the HFA-BDP group (59.9+/−17.0 years) than that in the FP group (55.8+/−16.6 yaers). The proportion of female patients was significantly higher not in the HFA-BDP (46.5%) but in the BUD group (59.0%) than in the FP group (51.1%). These results indicated that BUD was frequently prescribed to young female and HFA-BDP was employed in the elderly patients irrespective of gender compared with FP. Conclusions: Our study indicates that ICS selection is reasonably adapted to each patient's background at least in the surveyed area. We need to elucidate the characteristics of ICS selection further in the future as new ICS and devices are developed.http://www.sciencedirect.com/science/article/pii/S1323893015307188bronchial asthmainhaled corticosteroidJapanselection strategytherapy
collection DOAJ
language English
format Article
sources DOAJ
author Kyuma Ota
Takashi Hasegawa
Toshiyuki Koya
Takuro Sakagami
Takashi Sekikawa
Shinichi Toyabe
Kohei Akazawa
Masaaki Arakawa
Fumitake Gejyo
Eiichi Suzuki
spellingShingle Kyuma Ota
Takashi Hasegawa
Toshiyuki Koya
Takuro Sakagami
Takashi Sekikawa
Shinichi Toyabe
Kohei Akazawa
Masaaki Arakawa
Fumitake Gejyo
Eiichi Suzuki
Analysis of Inhaled Corticosteroid Selection in Patients with Bronchial Asthma Using a Questionnaire Survey—Effects of Age, Gender, and Disease Severity—
Allergology International
bronchial asthma
inhaled corticosteroid
Japan
selection strategy
therapy
author_facet Kyuma Ota
Takashi Hasegawa
Toshiyuki Koya
Takuro Sakagami
Takashi Sekikawa
Shinichi Toyabe
Kohei Akazawa
Masaaki Arakawa
Fumitake Gejyo
Eiichi Suzuki
author_sort Kyuma Ota
title Analysis of Inhaled Corticosteroid Selection in Patients with Bronchial Asthma Using a Questionnaire Survey—Effects of Age, Gender, and Disease Severity—
title_short Analysis of Inhaled Corticosteroid Selection in Patients with Bronchial Asthma Using a Questionnaire Survey—Effects of Age, Gender, and Disease Severity—
title_full Analysis of Inhaled Corticosteroid Selection in Patients with Bronchial Asthma Using a Questionnaire Survey—Effects of Age, Gender, and Disease Severity—
title_fullStr Analysis of Inhaled Corticosteroid Selection in Patients with Bronchial Asthma Using a Questionnaire Survey—Effects of Age, Gender, and Disease Severity—
title_full_unstemmed Analysis of Inhaled Corticosteroid Selection in Patients with Bronchial Asthma Using a Questionnaire Survey—Effects of Age, Gender, and Disease Severity—
title_sort analysis of inhaled corticosteroid selection in patients with bronchial asthma using a questionnaire survey—effects of age, gender, and disease severity—
publisher Elsevier
series Allergology International
issn 1323-8930
publishDate 2009-01-01
description Background: Inhaled corticosteroid (ICS) has played an important role in the management of asthma. Although several kinds of ICSs are currently available, there is no established strategy for ICS selection. Methods: Using the data from the 2004 questionnaire surveys by the Niigata Asthma Treatment Study Group, we analyzed relationships between each patient and the ICS employed on the basis of patient background, asthma control and treatment, and indicated characteristics of ICS selection by the physician. Results: Of 2852 cases, 2279 (79.9%) were ICS users, and 1513 (66.4% of ICS users) were classified as being in the fluticasone propionate (FP) group, 438 (19.2%) in the budesonide (BUD) group, and 240 (10.5%) in the hydrofluoroalkane-beclometasone (HFA-BDP) group, indicating that FP was a standard ICS in this study. The mean age was significantly lower in the BUD group (52.3+/−18.2 years) and was significantly higher in the HFA-BDP group (59.9+/−17.0 years) than that in the FP group (55.8+/−16.6 yaers). The proportion of female patients was significantly higher not in the HFA-BDP (46.5%) but in the BUD group (59.0%) than in the FP group (51.1%). These results indicated that BUD was frequently prescribed to young female and HFA-BDP was employed in the elderly patients irrespective of gender compared with FP. Conclusions: Our study indicates that ICS selection is reasonably adapted to each patient's background at least in the surveyed area. We need to elucidate the characteristics of ICS selection further in the future as new ICS and devices are developed.
topic bronchial asthma
inhaled corticosteroid
Japan
selection strategy
therapy
url http://www.sciencedirect.com/science/article/pii/S1323893015307188
work_keys_str_mv AT kyumaota analysisofinhaledcorticosteroidselectioninpatientswithbronchialasthmausingaquestionnairesurveyeffectsofagegenderanddiseaseseverity
AT takashihasegawa analysisofinhaledcorticosteroidselectioninpatientswithbronchialasthmausingaquestionnairesurveyeffectsofagegenderanddiseaseseverity
AT toshiyukikoya analysisofinhaledcorticosteroidselectioninpatientswithbronchialasthmausingaquestionnairesurveyeffectsofagegenderanddiseaseseverity
AT takurosakagami analysisofinhaledcorticosteroidselectioninpatientswithbronchialasthmausingaquestionnairesurveyeffectsofagegenderanddiseaseseverity
AT takashisekikawa analysisofinhaledcorticosteroidselectioninpatientswithbronchialasthmausingaquestionnairesurveyeffectsofagegenderanddiseaseseverity
AT shinichitoyabe analysisofinhaledcorticosteroidselectioninpatientswithbronchialasthmausingaquestionnairesurveyeffectsofagegenderanddiseaseseverity
AT koheiakazawa analysisofinhaledcorticosteroidselectioninpatientswithbronchialasthmausingaquestionnairesurveyeffectsofagegenderanddiseaseseverity
AT masaakiarakawa analysisofinhaledcorticosteroidselectioninpatientswithbronchialasthmausingaquestionnairesurveyeffectsofagegenderanddiseaseseverity
AT fumitakegejyo analysisofinhaledcorticosteroidselectioninpatientswithbronchialasthmausingaquestionnairesurveyeffectsofagegenderanddiseaseseverity
AT eiichisuzuki analysisofinhaledcorticosteroidselectioninpatientswithbronchialasthmausingaquestionnairesurveyeffectsofagegenderanddiseaseseverity
_version_ 1716755012964581376